135 related articles for article (PubMed ID: 808157)
41. A simple and rapid thin-layer chromatography method to follow the kinetics of product formation by 7,8-dihydro-6-hydroxymethylpterin pyrophosphokinase and 7,8-dihydropteroate synthetase.
Bock L; Butte W; Richter M; Seydel JK
Anal Biochem; 1978 May; 86(1):238-51. PubMed ID: 207198
[No Abstract] [Full Text] [Related]
42. Dihydropteroate synthase from Streptococcus pneumoniae: characterization of substrate binding order and sulfonamide inhibition.
Vinnicombe HG; Derrick JP
Biochem Biophys Res Commun; 1999 May; 258(3):752-7. PubMed ID: 10329458
[TBL] [Abstract][Full Text] [Related]
43. Structural studies of pterin-based inhibitors of dihydropteroate synthase.
Hevener KE; Yun MK; Qi J; Kerr ID; Babaoglu K; Hurdle JG; Balakrishna K; White SW; Lee RE
J Med Chem; 2010 Jan; 53(1):166-77. PubMed ID: 19899766
[TBL] [Abstract][Full Text] [Related]
44. Evolution of a natural dihydropteroate synthase and development of a signal amplified fluorescence method for detection of 44 sulfonamides in milk.
He T; Liu J; Wang JP
Anal Chim Acta; 2022 Nov; 1234():340481. PubMed ID: 36328719
[TBL] [Abstract][Full Text] [Related]
45. A rapid assay for dihydropteroate synthase activity suitable for identification of inhibitors.
Fernley RT; Iliades P; Macreadie I
Anal Biochem; 2007 Jan; 360(2):227-34. PubMed ID: 17134675
[TBL] [Abstract][Full Text] [Related]
46. The characteristics and significance of sulfonamides as substrates for Escherichia coli dihydropteroate synthase.
Roland S; Ferone R; Harvey RJ; Styles VL; Morrison RW
J Biol Chem; 1979 Oct; 254(20):10337-45. PubMed ID: 385600
[No Abstract] [Full Text] [Related]
47. Sulfa drugs strike more than once.
Patel OG; Mberu EK; Nzila AM; Macreadie IG
Trends Parasitol; 2004 Jan; 20(1):1-3. PubMed ID: 14700578
[No Abstract] [Full Text] [Related]
48. Cloning and characterization of a DNA fragment that confers sulfonamide resistance in a serogroup B, serotype 15 strain of Neisseria meningitidis.
Kristiansen BE; Rådström P; Jenkins A; Ask E; Facinelli B; Sköld O
Antimicrob Agents Chemother; 1990 Nov; 34(11):2277-9. PubMed ID: 2127350
[TBL] [Abstract][Full Text] [Related]
49. Novel inhibitors of cyclooxygenase-2: the sulfones and sulfonamides of 1,2-diaryl-4,5-difluorobenzene. Analysis of quantitative structure-activity relationship.
Singh P; Kumar R
J Enzyme Inhib; 1998 Sep; 13(6):409-17. PubMed ID: 9825305
[TBL] [Abstract][Full Text] [Related]
50. Mutations in folP associated with elevated sulfonamide MICs for Neisseria meningitidis clinical isolates from five continents.
Fiebelkorn KR; Crawford SA; Jorgensen JH
Antimicrob Agents Chemother; 2005 Feb; 49(2):536-40. PubMed ID: 15673729
[TBL] [Abstract][Full Text] [Related]
51. Sulfonamide resistance in clinical isolates of Campylobacter jejuni: mutational changes in the chromosomal dihydropteroate synthase.
Gibreel A; Sköld O
Antimicrob Agents Chemother; 1999 Sep; 43(9):2156-60. PubMed ID: 10471557
[TBL] [Abstract][Full Text] [Related]
52. Pterin-sulfa conjugates as dihydropteroate synthase inhibitors and antibacterial agents.
Zhao Y; Shadrick WR; Wallace MJ; Wu Y; Griffith EC; Qi J; Yun MK; White SW; Lee RE
Bioorg Med Chem Lett; 2016 Aug; 26(16):3950-4. PubMed ID: 27423480
[TBL] [Abstract][Full Text] [Related]
53. Crystal structure of the anti-bacterial sulfonamide drug target dihydropteroate synthase.
Achari A; Somers DO; Champness JN; Bryant PK; Rosemond J; Stammers DK
Nat Struct Biol; 1997 Jun; 4(6):490-7. PubMed ID: 9187658
[TBL] [Abstract][Full Text] [Related]
54. Exploring the catalytic mechanism of dihydropteroate synthase: elucidating the differences between the substrate and inhibitor.
Chotpatiwetchkul W; Boonyarattanakalin K; Gleeson D; Gleeson MP
Org Biomol Chem; 2017 Jul; 15(26):5593-5601. PubMed ID: 28639657
[TBL] [Abstract][Full Text] [Related]
55. Sulfonamide resistance in Streptococcus pneumoniae: DNA sequence of the gene encoding dihydropteroate synthase and characterization of the enzyme.
Lopez P; Espinosa M; Greenberg B; Lacks SA
J Bacteriol; 1987 Sep; 169(9):4320-6. PubMed ID: 3114239
[TBL] [Abstract][Full Text] [Related]
56. Sulfonamide resistance in Streptococcus pyogenes is associated with differences in the amino acid sequence of its chromosomal dihydropteroate synthase.
Swedberg G; Ringertz S; Sköld O
Antimicrob Agents Chemother; 1998 May; 42(5):1062-7. PubMed ID: 9593127
[TBL] [Abstract][Full Text] [Related]
57. In vitro activity of sulfonamides and sulfones against Leishmania major promastigotes.
Peixoto MP; Beverley SM
Antimicrob Agents Chemother; 1987 Oct; 31(10):1575-8. PubMed ID: 3435106
[TBL] [Abstract][Full Text] [Related]
58. The uptake of 35S sulfadiazine by sulfonamide-sensitive and resistant Neisseria meningitidis with reference to its mode of action.
Vaichulis EM; Vedros NA
Chemotherapy; 1971; 16(3):153-61. PubMed ID: 4997984
[No Abstract] [Full Text] [Related]
59. Cell-free dihydropteroate synthetase activity: its use to investigate the relationship between structure and activity of p-aminobenzoic derivatives.
Thijssen HH
Methods Enzymol; 1980; 66():570-6. PubMed ID: 6990197
[No Abstract] [Full Text] [Related]
60. Evaluation of sulfa drugs against recombinant Pneumocystis carinii dihydropteroate synthetase and in vivo.
Hong YL; Hossler P; Bartlett M; Queener S; Smith J; Meshnick S
J Eukaryot Microbiol; 1996; 43(5):40S. PubMed ID: 8822843
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
